Omega Therapeutics News

Omega Therapeutics | 8-K: Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress

Aug 6 07:08 ET

Omega Therapeutics | 8-K: Current report

Jun 24 16:06 ET

Omega Therapeutics | 8-K/A: Current report (Amendment)

May 30 17:13 ET

Omega Therapeutics | 8-K: Current report

May 30 17:13 ET

Omega Therapeutics | 8-K: Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress

May 6 07:08 ET

Omega Therapeutics | DEFA14A: Others

Apr 29 07:18 ET

Omega Therapeutics | DEF 14A: Definitive information statements

Apr 29 07:02 ET

Omega Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 19 16:05 ET

Omega Therapeutics | 8-K: Current report

Apr 16 16:21 ET

Omega Therapeutics | 8-K: Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update

Mar 28 16:21 ET

Omega Therapeutics | 8-K: Current report

Jan 5 00:00 ET

Omega Therapeutics | 8-K: Current report

Dec 11, 2023 16:00 ET

Omega Therapeutics | 8-K: Omega Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress

Nov 9, 2023 07:03 ET

Omega Therapeutics | 8-K: Current report

Sep 26, 2023 17:29 ET

Omega Therapeutics | 8-K: Current report

Sep 22, 2023 17:10 ET

Omega Therapeutics | 8-K: Current report

Aug 29, 2023 07:03 ET

Omega Therapeutics | 8-K: Current report

Aug 3, 2023 17:13 ET

Omega Therapeutics | 8-K: Current report

Jul 13, 2023 16:00 ET

Omega Therapeutics | 8-K: Current report

Jul 12, 2023 16:01 ET

Omega Therapeutics | 8-K: Current report

Jun 12, 2023 16:02 ET